Shay Capital LLC - 19 Sep 2025 SCHEDULE 13G Report for LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share (LVTX)

Filing Manager: Shay Capital LLC
Reporting Manager: Shay Capital LLC
Security: LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share
Symbol: LVTX
Shares outstanding: 26,226,293 shares
Disclosed Ownership: 2,596,403 shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 26 Sep 2025, 16:01:22 UTC
Date of event: 19 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Shay Capital LLC	9.9%	2,596,403	2,596,403	0	Elan Foxman	Chief Financial Officer
Shay Capital Holdings LLC	9.9%	2,596,403	2,596,403	0	Elan Foxman	Chief Financial Officer